1-3 of 3
Bradley W. McIntyre
Close
Sort by
Journal Articles

The PI3 Kinase δ Inhibitor, CAL-101 (GS-1101), Inhibits Chronic Lymphocytic Leukemia (CLL) Cell Survival in Endothelial and Marrow Stromal Cell Co-Cultures.

Stefania Fiorcari, Wells S Brown, Bradley W McIntyre, PhD, Susan O'Brien, MD, Mariela Sivina, PhD, Julia Hoellenriegel, William G. Wierda, MD, PhD, Michael J Keating, MD, Roberto Marasca, Brian J. Lannutti, PhD, Zeev Estrov, Jan A. Burger, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1769.
https://doi.org/10.1182/blood.V118.21.1769.1769
Published: 2011
Journal Articles

An anti–PR1/HLA-A2 T-cell receptor–like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells

Anna Sergeeva, Gheath Alatrash, Hong He, Kathryn Ruisaard, Sijie Lu, James Wygant, Bradley W. McIntyre, Qing Ma, Dan Li, Lisa St John, Karen Clise-Dwyer, Jeffrey J. Molldrem
Journal: Blood
Blood (2011) 117 (16): 4262–4272.
https://doi.org/10.1182/blood-2010-07-299248
Published: 2011
Includes: Supplemental data
Journal Articles

Targeting of alpha4beta1 Integrin and CD4/CD8 on Human T Cells, in Addition to CD3 and CD28, Induces Maximal Activation, as Assessed by Single-Cell Analysis of MAP Kinase Pathway Activation and Cytokine Production.

Tae Kon Kim, M.D., Matthew J. Billard, Ph.D., Eric D. Wieder, Ph.D., Bradley W. McIntyre, Ph.D., Krishna V. Komanduri, M.D.
Journal: Blood
Blood (2008) 112 (11): 1538.
https://doi.org/10.1182/blood.V112.11.1538.1538
Published: 2008